| Literature DB >> 31858746 |
Siraj Patwa1,2, Curtis A Benson1,2, Lauren Dyer1,2, Kai-Lan Olson1,2, Lakshmi Bangalore1,2, Myriam Hill1,2, Stephen G Waxman1,2, Andrew M Tan1,2.
Abstract
Burn injuries and associated complications present a major public health challenge. Many burn patients develop clinically intractable complications, including pain and other sensory disorders. Recent evidence has shown that dendritic spine neuropathology in spinal cord sensory and motor neurons accompanies central nervous system (CNS) or peripheral nervous system (PNS) trauma and disease. However, no research has investigated similar dendritic spine neuropathologies following a cutaneous thermal burn injury. In this retrospective investigation, we analyzed dendritic spine morphology and localization in alpha-motor neurons innervating a burn-injured area of the body (hind paw). To identify a molecular regulator of these dendritic spine changes, we further profiled motor neuron dendritic spines in adult mice treated with romidepsin, a clinically approved Pak1-inhibitor, or vehicle control at two postburn time points: Day 6 immediately after treatment, or Day 10 following drug withdrawal. In control treated mice, we observed an overall increase in dendritic spine density, including structurally mature spines with mushroom-shaped morphology. Pak1-inhibitor treatment reduced injury-induced changes to similar levels observed in animals without burn injury. The effectiveness of the Pak1-inhibitor was durable, since normalized dendritic spine profiles remained as long as 4 days despite drug withdrawal. This study is the first report of evidence demonstrating that a second-degree burn injury significantly affects motor neuron structure within the spinal cord. Furthermore, our results support the opportunity to study dendritic spine dysgenesis as a novel avenue to clarify the complexities of neurological disease following traumatic injury.Entities:
Keywords: burn injury; central sensitization; dendritic spines; motor neuron; pain; reflex control
Mesh:
Substances:
Year: 2019 PMID: 31858746 PMCID: PMC6923170 DOI: 10.14814/phy2.14288
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Figure 1Golgi‐stained tissue from the ventral spinal cord. (a) Coronal section of spinal cord showing a representative alpha‐motor neuron within lamina IX ventral horn (asterisk with black arrow). (b) Magnified motor neuron from panel a (green highlight). (c) Dendritic branch segments from alpha‐motor neurons sampled from each group: Sham, Burn + DMSO (Day 6), Burn + DMSO (Day 10), Burn + anti‐Pak1 (Day 6), and Burn + anti‐Pak1 (Day 10 withdrawal). Magnified view of multiple dendritic spines along a sampled dendritic branch is shown from the red box in panel c. Scale bars in A = 100 μm; B = 50 μm C = 10 μm
Cell body dimensions and dendritic branch morphology comparison
| Maximum diameter of cell body (µm) | # of Primary dendrites | Primary dendrites with secondary branches (%) | |
|---|---|---|---|
| Sham | 51.2 ± 6.7 | 5.2 ± 1.3 | 49.3 ± 19.5 |
| Burn + DMSO (D6) | 52.8 ± 10.1 | 4.4 ± 1.6 | 42.1 ± 16.4 |
| Burn + anti‐Pak1(D6) | 50.8 ± 10.0 | 5.8 ± 1.6 | 44.8 ± 17.6 |
| Burn + DMSO (D10) | 45.8 ± 7.8 | 4.1 ± 1.0 | 58.7 ± 21.2 |
| Burn + anti‐Pak1(D10) | 50.6 ± 6.4 | 5.2 ± 1.6 | 41.5 ± 15.6 |
To determine if there were any morphological differences across our sample neurons, we used NeuroExplorer software (MicroBrightfield, Williston, VT) to measure maximum cell diameter, number of primary dendrites, and their percentage of primary dendrites with secondary branches, and compared these morphometry values across treatment groups. Data are mean ± standard deviation (SD).
No statistical differences in any comparisons across groups (p > .05).
Figure 3Dendritic spine density on alpha‐motor neurons. 6 days after burn injury, (a) total, (b) thin, and (c) mushroom dendritic spine density increased on ipsilateral motor neurons following second‐degree burn injury treated with control DMSO, as compared with Sham (* within bar = p < .05). At 10‐days postburn injury with DMSO treatment, dendritic spine density for all types also remained elevated as compared with Sham (* within bar = p < .05). Although treatment with anti‐Pak1, romidepsin, reduced total and thin‐shaped dendritic spine density at Day 6 and following the drug's withdrawal by Day 10 following burn injury, romidepsin had no significant effect on mushroom‐shaped dendritic spines following burn injury on alpha‐motor neurons. In general, there was no difference in dendritic spines in burn‐injured animals treated with anti‐Pak1‐inhibitor and Sham animals (n.s.). Data are shown as mean ± SEM
Figure 4Spatial distribution of dendritic spines. (a) Total, (b) thin‐, and (c) mushroom‐shaped dendritic spines on alpha‐motor neurons increased in the two closest regions within 100 μm away from the cell body 6 days following burn injury with control DMSO treatment, as compared with Sham (*p < .05). Treatment with anti‐Pak1‐inhibitor in burn‐injured animals significantly reduced total and thin‐shaped dendritic spine densities as compared with DMSO‐treated animals (# p < .05). As shown in panel c, there was no effect of romidepsin anti‐Pak1 treatment on mushroom‐shaped dendritic spines on alpha‐motor neurons, in comparisons with DMSO‐treated burn‐injured animals or Sham (n.s.). Following withdrawal drug and assessing dendritic spine profiles 10 days following burn injury, most dendritic spine densities remained elevated in regions closest to the cell body for (d) total, (e) thin‐, and (f) mushroom‐shaped dendritic spines as compared with Sham (*p < .05). As shown in data from Day 10 postburn injury, treatment with anti‐Pak1‐inhibitor continued to be partly effective in reducing total and thin‐shaped dendritic spines despite drug withdrawal, as compared with Sham (# p < .05). As with Day 6, romidepsin anti‐Pak1 inhibition had no effect on mushroom‐shaped dendritic spines in the Day 10 dataset (n.s.). In animals treated with romidepsin, dendritic spine densities for all types were not significant in comparisons with Sham, suggesting that anti‐Pak1 treatment restored and maintained close‐to‐normal spine densities on alpha‐motor neurons. Data are shown as mean ± SEM
Figure 2Neurolucida digital reconstruction of alpha‐motor neurons. Digital rendering shows the morphology of a representative alpha‐motor neuron from (a) Sham, (b) Burn + DMSO (Day 6), (c) Burn + anti‐Pak1 (Day 6), (d) Burn + DMSO (Day 10), and (e) Burn + anti‐Pak1 (Day 10 withdrawal). Gray shaded boxes in each panel show a magnified view of a dendritic branch segment with thin (blue dots) and mushroom (red dots) dendritic spines. Scale bars a–c = 50 μm
Retrospective view of dendritic spine density: dorsal horn sensory neurons versus ventral horn motor neurons
| Treatment arm | Dorsal horn sensory neurons | Ventral horn motor neurons |
|---|---|---|
| Total spine density | ||
| Burn + anti‐Pak1 (Day 6) | 2.8 ± 0.4 | 0.59 ± 0.19 |
| Burn + DMSO (Day 6) | 3.5 ± 0.6 | 1.11 ± 0.32 |
| Burn + anti‐Pak1 (Day 10) | 2.9 ± 0.6 | 0.59 ± 0.31 |
| Burn + DMSO (Day 10) | 3.1 ± 1.1 | 1.0 ± 0.17 |
| Sham | 2.4 ± 0.4 | 0.60 ± 0.13 |
| Thin spine density | ||
| Burn + anti‐Pak1 (Day 6) | 2.4 ± 0.3 | 0.53 ± 0.16 |
| Burn + DMSO (Day 6) | 2.9 ± 0.7 | 1.0 ± 0.26 |
| Burn + anti‐Pak1 (Day 10) | 2.5 ± 0.4 | 0.55 ± 0.29 |
| Burn + DMSO (Day 10) | 2.6 ± 0.9 | 0.86 ± 0.17 |
| Sham | 2.1 ± 0.4 | 0.56 ± 0.13 |
| Mushroom spine density | ||
| Burn + anti‐Pak1 (Day 6) | 0.43 ± 0.2 | 0.05 ± 0.05 |
| Burn + DMSO (Day 6) | 0.58 ± 0.2 | 0.11 ± 0.08 |
| Burn + anti‐Pak1 (Day 10) | 0.47 ± 0.2 | 0.04 ± 0.05 |
| Burn + DMSO (Day 10) | 0.48 ± 0.3 | 0.1 ± 0.07 |
| Sham | 2.8 ± 0.4 | 0.03 ± 0.02 |
Summary table showing the retrospective datasets of burn injury on ventral horn motor neuron dendritic spine density as compared with published data on sensory neurons following second‐degree burn injury (Guo et al., 2018). Dendritic spine density is measured as number of spines per 10 mm dendritic branch length. In all comparisons, dorsal horn exhibited a greater density of dendritic spines than compared with ventral horn neurons (*p < .01).
Datasets from previous publication Guo et al., 2018
Denotes statistically significant increase in dendritic spine density following burn injury as compared with Sham control (no burn) data.
Denotes a statistically significant effect of anti‐Pak1 (romidepsin) drug treatment as compared with DMSO treatment, in burn‐injured animals within the same time point (i.e., Day 6 or Day 10 post drug withdrawal).